Overland Therapeutics
- Biotech or pharma, therapeutic R&D
Overland Therapeutics is a clinical-stage biotechnology company focused on developing innovative cell therapies for oncology and autoimmune diseases. Our lead program, OL-101, is a fully optimized bispecific CAR-T therapy targeting GPRC5D and BCMA, currently in phase 1 clinical trials. Beyond oncology, Overland is pioneering a suite of off-the-shelf allogeneic gamma delta CAR-T programs for autoimmune disorders.
Address
South San FranciscoCalifornia
United States
)
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}